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ABSTRACT 
Introduction: The omega-3 fatty acids, eicosapentaenoic (EPA) and docosahexaenoic acid 
(DHA), have many health benefits such as reducing risks of heart disease, cancer and depression. 
EPA and DHA are found in oily fish and are also available in dietary supplements. The 2010 
Dietary Guidelines for Americans recommend 1,750 mg EPA and DHA/wk, or 250 mg/day, 
which can be reached by consuming 8 ounces of seafood/week. For many people, achieving this 
recommended amount of EPA and DHA through diet alone may be difficult unless supplements 
are also used. Though the health benefits of fish oil are relatively clear, the content, purity and 
price of EPA and DHA needed for the recommended dosage is highly confusing. Purpose: To 
compare the content and cost of omega-3 supplements in order to assist practitioners and 
consumers in making choices about purchasing an omega-3 supplement. Methods: Thirteen 
randomly sampled dietary omega-3 supplements available in retail stores were analyzed. Oils 
were extracted and prepared for analysis by gas chromatography. After quantifying the levels of 
numerous fatty acids including EPA and DHA, a cost analysis was performed for each 
supplement based on retailer’s list prices per unit (e.g., gram of oil), recommended dosage and 
composition. Results: Fish oil pills available for consumers varied greatly in content and price. 
The amount of DHA + EPA ranged from 10 mg/g to 894 mg/g EPA and DHA. The prices also 
varied from $0.03 per pill, to $1.23 per pill. Summary: Results from these analyses should clarify 
confusion regarding content and price per recommended serving of fish oil supplements, while 
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also enhancing the health and quality of life for the millions of Americans suffering from 
diseases that may be prevented with adequate dietary intake of omega-3 fatty acids. 
INTRODUCTION 
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 
polyunsaturated fatty acids (PUFAs) and are precursors of eicosanoids. EPA and DHA are 
marketed in fish oil supplements and can be found in oily fish such as salmon, tuna, and herring. 
Arachidonic acid and linoleic acid are omega-6 PUFAs and precursors of prostaglandins and 
eicosanoids. Refined vegetable oils such as safflower, sunflower, and corn oils contain α-linoleic 
acid (1). Both α-linolenic and linoleic acid cannot be made by the body and must be obtained 
through diet (2). Although EPA and DHA can be synthesized from their precursor, α-linoleic 
acid, studies show that this is not very efficient and that tissue growth depends significantly on 
consumption of EPA and DHA through dietary sources (3,4). While EPA and DHA lead to 
reduced inflammation, arachidonic acid increases the production of proinflammatory cytokines 
(1). Thus, the ratio of omega-6 to omega-3 fatty acids may be very important in disease 
prevention and control.  
Evolutionally, the omega-6/omega-3 ratio in hunter-gatherer diets was approximately 2:1 
(5). Western diets are high in omega-6 fatty acids, and deficient in omega-3 fatty acids, leading 
to a ratio of about 16:1. (1,5). This high omega-6 to omega-3 ratio in the diet has been shown to 
promote various diseases such as cancer, inflammatory and autoimmune diseases, and 
cardiovascular disease. By increasing levels of omega-3 PUFAs, Americans can lower their 
omega-6/omega-3 ratio and this optimal ratio can potentially reduce the risk of many chronic 
diseases (2).  
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Coronary Heart Disease 
Consumption of EPA and DHA reduces the risk of coronary heart disease by lowering 
triglyceride levels and blood pressure (6). Studies have shown that those who incorporate fish 
into their diets had a lower risk of mortality from coronary heart disease (7-10). 
Cancer 
Fish oil supplementation has also been found to display potential anti-cancer effects (11). 
Studies have shown that more aggressive tumor characteristics and increased mammary tumor 
promotion are linked with high levels of linoleic acids in the diet (12, 13). Fish oil 
supplementation has also been shown to improve quality of life and reduce weight loss in 
patients with cancer-related cachexia. An EPA enriched diet may have the ability to decrease the 
production of tumor necrosis factor (TNF),  a potential mediator of cachexia, while also 
displaying a direct effect on tumor growth kinetics (14). Nude mice with xenografts of human 
breast cancer fed EPA and DHA enriched diets displayed suppression of tumor growth and 
metastasis (15).  
Depression 
EPA and DHA consumption can also reduce depression and suicide (16). Depressive 
symptoms have also been linked to cardiovascular disease, which is the leading cause of death in 
the United States. Studies have shown that depressed patients tend to have lower levels of 
omega-3 PUFAs then nondepressed control patients (1, 17).  
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Alzheimer’s and Parkinson’s disease 
Fish oil supplementation can also positively impact the brain in relation to cognitive 
problems accompanied by Alzheimer's disease and Parkinson's (18).  Lower intakes of EPA and 
DHA have been associated with increased risk of Alzheimer’s disease. Omega-3 fatty acids are 
recommended in prevention of CVD and AD (19). Learning and cognitive development are also 
positively impacted by omega-3 fatty acids (20).  
Dietary Guidelines 
Because of the health benefits of EPA and DHA, in 2010, the Dietary Guidelines for 
Americans recommend 1,750 mg EPA and DHA per week, which translates to approximately 
250 mg per day, and can be reached by consuming 8 ounces of seafood per week. For many 
people, achieving the recommended amount of EPA and DHA may best be achieved through 
supplements. Though the health benefits of fish oil are relatively clear, there are numerous 
brands available to the public, in various quantities and forms that are confusing in terms of 
‘consumer understanding’ and also financially burdensome. Through analyzing the content and 
price of several fish oil supplements available on the market, my project seeks to provide clarity 
and guidance for consumers to make an informed and knowledgeable decision concerning their 
fish oil supplement brand.  
METHODS 
Thirteen randomly sampled dietary omega-3 supplements available in retail stores were 
analyzed. Oils were extracted from capsules and prepared for analysis by gas chromatography. 
After quantifying the levels of numerous fatty acids including EPA and DHA, a cost analysis 
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was performed for each supplement based on retailer’s list prices per unit (e.g., gram of oil), 
recommended dosage and composition. 
Fatty acid methyl esters were prepared from the oils using 5% hydrochloride acid in 
methanol at 76˚C (5).Each capsule was analyzed in duplicates (when available) and C17:0 was 
used as the internal standard. A syringe was used to extract the oil from the fish oil supplement 
capsule and about 2-3 drops of the oil was placed into previously weighed glass test tube. The 
test tube was then reweighed after the addition of  the oil in order to calculate the grams of oil 
used in analysis from each capsule. One ml of 5% Hydrochloric Acid in Methanol was added to 
the oil to methylate the fat. The internal standard was prepared in the 5% HCl in MeOH at a 
concentration of 100ug/ml.  The samples were capped tightly, vortexed and  heated in a bead 
bath at 76º C overnight.  
After removing the samples from the bead bath the next day, 1 mL of hexane  and 0.5ml 
of 0.88% KCl were added to each sample. The samples were capped tightly, vortexed, and 
placed in a centrifuge at 1000g for 10 minutes at 4ºC. After removing the sample from the 
centrifuge, the top hexane phase was transferred to a new glass test tube with a glass pipette. One 
mL of hexane was added to the remaining bottom aqueous phase. After vortexing the samples 
and centrifuging again at 1000g for 10 minutes at 4ºC, the top hexane phase was once again 
removed and combined with the top hexane phase from the prior transfer. The hexane was dried 
under a steady stream of nitrogen at room temperature until completely dry. The samples were 
weighed and 2 mL of hexane was added to each sample.  The samples were vortexed and  300 ul 
was transferred to a GC vial. Samples were stored at -20 ºC until GC analysis.  
5 
 
Analysis of fatty acid methyl esters was completed by gas chromatography (GC) using a 
30-m Omegawax™320 fused silica capillary column (Supelco, Bellefonte, PA). Oven 
temperature started at 175˚C and increased at a rate of 3˚ C/min until reaching 220˚C. Flow rate 
of the carrier gas helium was 30 mL/min. Retention times of samples were compared to 
standards for fatty acid methyl esters (Matreya, LLC, Pleasant Gap, PA, Supelco, Bellefonte, PA 
and Nu-Check Prep Inc, Elysian, MN) Fatty acids are reported as percent of total identified fatty 
acids and EPA and DHA were also reported as mg/g of oil.  
Prices of the various fish oil supplement brands were collected in March 2011 from 
respective stores or websites. To calculate price per pill of the different brands, the total price of 
the bottle was then divided by the quantity of pills in the bottle. The required dosage of the 
brands was then addressed and the price per recommended dosage was calculated by multiplying 
the price per pill by the amount of pills recommended to take each day. The manufacturer’s 
recommended EPA and DHA dosage was then calculated for the total amount of EPA and DHA 
per day, and then correlated with the price per day.   
RESULTS 
Table 1 shows the brands of the 13 fish oil supplements and the EPA and DHA content, 
along with prices based on the label. Prices per pill ranged from $0.03 to $1.23 per pill, and price 
per day ranged from $0.09 per day to $1.23 per day. Manufacturer’s stated EPA and DHA 
content per recommended dosage ranged from 200 mg EPA and DHA per day to 1440 mg EPA 
and DHA per day.  
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Table 1: Brands and prices of thirteen fish oil supplements 
 
 
Sample Brand 
Amount 
Per Pill
Price per 
bottle
Price per 
pill Price per day Dose
EPA+DHA Dose per 
day
A Nature Made Liquid Softgel Double Strength  1200 mg $17.47 $0.19 $0.39 2 softgels 1 time daily 1224 mg
B Nature Made  1200 mg $16.99 $0.17 $0.68 2 softgels 2 times daily 1440 mg*
C Origin Purified to eliminate mercury   1200 mg $5.00 $0.05 $0.20 2 softgels 2 times daily 1440*
D Vital Oils 1000 1000 mg $36.95 $1.23 $1.23 1 softgel daily 1000 mg
E Origin Triple Strength 1360 mg $8.99 $0.30 $0.30 1 softgel daily 950 mg*
F Member's Mark Triple Strength  1400 mg  $29.95 $0.20 $0.20 1 softgel daily 900 mg
G Finest Natural  1400 mg  $11.99 $0.20 $0.20 1 softgel daily 900 mg
H Spring Valley  1400 mg  $14.97 $0.25 $0.25 1 softgel daily 900 mg
I Origin Odorless, Purified to eliminate mercury  1200 mg  $19.07 $0.07 $0.21 1 softgel 3 times daily 1080 mg*
J Kirkland Signature  1000 mg $8.99 $0.03 $0.09 1 softgel 3 times daily 900 mg*
K Animal Hospital  ND ND ND ND ND ND
L Nordic Naturals Purified Fish Oil with Vitamin D 1000mg $28.95 $0.48 $0.97 2 softgels daily 1100 mg
M Expecta  200 mg $24.19 $0.81 $0.81 1 softgel daily 200 mg
 
 
*includes other Omega‐3 fatty acids 
ND=No Data Available 
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Figure 1: EPA and DHA Composition  
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Values are expressed as average percent of total identified fatty acids. Samples A-M were averaged between two pills 
and the results of the averages were used to represent EPA and DHA content per pill. EPA, eicosapentaenoic acid; DHA, 
docosahexaenoic acid. 
The thirteen different fish oil supplements vary in their amounts of EPA and DHA. The 
highest amount of EPA and DHA from the selected supplement brands was 894.0 mg/g and the 
lowest amount of EPA and DHA was 10.2 mg/g, which was a difference of 883.8 mg/g EPA and 
DHA.  
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Figure 2: Average Percent of Fat 
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Values are expressed as average percent of total identified fatty acids. Total SFA, total saturated fatty acids; Total Mono, total 
monounsaturated fatty acids; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. 
The thirteen different fish oil supplements also varied in average percent fat. The 
composition of fats and which specific fat each supplement contains is important information for 
consumers to be aware of because this may affect their daily total consumption of certain fats, 
like saturated fat. Sample B has slightly higher amounts of saturated fatty acids than other 
brands, so if a consumer already is near the upper limit of dietary saturated fat intake, they might 
want to choose a supplement with a lower saturated fatty acid content.  
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Table 2: Average Percent of Fat  
 
 
 
 
 
%Fat
Total SFA 6.2 ± 0.0 34.8 ± 0.1 31.9 ± 0.0 0.1 ± 0.0 3.0 ± 0.0
Total Mono 12.8 ± 0.0 24.7 ± 0.0 25.5 ± 0.0 0.3 ± 0.0 8.5 ± 0.0
omega 6 4.6 ± 0.0 2.5 ± 0.0 2.6 ± 0.0 7.5 ± 0.0 4.9 ± 0.0
omega 3 75.7 ± 0.0 33.0 ± 0.1 34.2 ± 0.1 92.1 ± 0.0 83.2 ± 0.0
omega 6:omega 3 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
EPA 39.6 ± 0.0 19.3 ± 0.1 20.5 ± 0.1 26.4 ± 0.0 51.5 ± 0.0
DHA 26.5 ± 0.0 7.3 ± 0.1 7.2 ± 0.0 63.0 ± 0.0 22.5 ± 0.0
EPA:DHA 1.5 ± 0.0 2.6 ± 0.0 2.9 ± 0.0 0.4 ± 0.0 2.3 ± 0.0
EPA+DHA 66.1 ± 0.0 26.6 ± 0.1 27.7 ± 0.1 89.4 ± 0.0 74.0 ± 0.0
CBA ED
 
 
 
 
 
 
 
 
 
 
Values are expressed as percent of total identified fatty acids ± standard deviation. Total SFA, total saturated fatty 
acids; Total Mono, total monounsaturated fatty acids; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.  
 
%Fat
Total SFA 4.291 ± 0 3.749 ± 0 3.766 ± 0 33.87 ± 0.1 33.04 ± 0
Total Mono 9.411 ± 0 9.352 ± 0 9.423 ± 0 25.07 ± 0 26.66 ± 0.1
omega 6 4.752 ± 0 5.078 ± 0 5.049 ± 0 3.022 ± 0 3.279 ± 0
omega 3 81.16 ± 0 81.49 ± 0 81.4 ± 0 32.25 ± 0 32.43 ± 0.1
omega 6:omega 3 0.059 ± 0 0.062 ± 0 0.062 ± 0 0.094 ± 0 0.101 ± 0
EPA 56.04 ± 0 57.02 ± 0 57.01 ± 0 20.38 ± 0 17.82 ± 0.1
DHA 17.42 ± 0 17.49 ± 0 17.51 ± 0 6.169 ± 0 8.505 ± 0.1
EPA:DHA 3.216 ± 0 3.261 ± 0 3.256 ± 0 3.304 ± 0 2.1 ± 0
EPA+DHA 73.46 ± 0 74.51 ± 0 74.52 ± 0 26.55 ± 0.1 26.33 ± 0.1
F G H I J
%Fat
Total SFA 16.9 ± 0 32.43 ± 0 41.22 ± 0.1
Total Mono 24.11 ± 0 25.4 ± 0 9.431 ± 0
omega 6 51 ± 0 3.564 ± 0 13.42 ± 0
omega 3 7.765 ± 0 33.7 ± 0 35.65 ± 0
omega 6:omega 3 6.568 ± 0 0.106 ± 0 0.377 ± 0
EPA 0.501 ± 0 17.98 ± 0 1.283 ± 0
DHA 0.52 ± 0 9.166 ± 0 32.69 ± 0
EPA:DHA 0.963 ± 0 1.962 ± 0 0.039 ± 0
EPA+DHA 1.021 ± 0 27.14 ± 0 33.97 ± 0.1
K L M
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Table 2 expresses the total saturated fatty acids, total monounsaturated fatty acids, total 
omega-6 fatty acids, total omega-3 fatty acids, the omega-6 to omega-3 ratio, EPA content, DHA 
content, the ratio of EPA to DHA, along with the amount of EPA and DHA averaged across each 
pill. A ratio of EPA: DHA is important in seeking to maintain an optimal EPA: DHA ratio in the 
diet.  
 
Figure 3: Mg/g Methylated oil 
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Values are expressed as average percent of total identified fatty acids. Total SFA, total saturated fatty acids; Total Mono, total 
monounsaturated fatty acids; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. 
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Figure 3 shows that the thirteen various fish oil supplements varied in contents of total 
saturated fatty acids, total monounsaturated fatty acids, omega-6, omega-3, EPA and DHA. 
Sample D (Vital Oils 1000) had the highest amount of DHA at 629.9 mg/g DHA, and 894.4 
mg/g total EPA and DHA, but this is also the pill that would cost a consumer $1.23 per day to 
consume. Comparable amounts of EPA and DHA can be achieved by choosing a supplement like 
E (Origin Triple Strength Fish Oil), at that would cost the consumer $0.30 per day and provide 
740 mg/g EPA and DHA. 
 
Table 3: Mg/g Methylated oil  
 
 
 
 
 
mg/g methylated oil 
Total SFA 15.4 ± 1.8 86.9 ± 12.8 79.6 ± 11.6 0.2 ± 0.0 7.4 ± 1.1
Total Mono 32.1 ± 5.2 61.7 ± 8.3 63.8 ± 8.3 0.8 ± 0.1 21.3 ± 2.3
omega 6 6.9 ± 0.8 4.1 ± 0.6 4.3 ± 0.6 10.8 ± 2.6 7.3 ± 1.2
omega 3 126.2 ± 15.1 55.0 ± 3.8 57.0 ± 3.7 153.5 ± 38.7 138.6 ± 12.9
omega 6:omega 3 0.1 ± 0.1 0.1 ± 0.2 0.1 ± 0.2 0.1 ± 0.1 0.1 ± 0.1
EPA 395.7 ± 0.2 192.6 ± 0.6 205.2 ± 0.6 264.1 ± 0.1 515.0 ± 0.2
DHA 264.8 ± 0.1 73.4 ± 0.8 72.1 ± 0.5 629.9 ± 0.3 225.0 ± 0.1
EPA:DHA 1.5 ± 1.5 2.6 ± 0.8 2.8 ± 1.2 0.4 ± 0.4 2.3 ± 1.2
EPA + DHA 660.5 ± 0.4 266 ± 1.4 277.3 ± 1.1 894 ± 0.4 740.1 ± 0.3
EDCBA
 
 
 
 
 
mg/g methylated oil 
Total SFA 10.73 ± 2 9.372 ± 1.8 9.416 ± 1.8 84.68 ± 12 82.6 ± 12
Total Mono 23.53 ± 3.5 23.38 ± 3.5 23.56 ± 3.5 62.67 ± 8.4 66.66 ± 8.4
omega 6 7.158 ± 1.2 7.65 ± 1.3 7.615 ± 1.3 4.879 ± 0.7 5.209 ± 0.9
omega 3 135.3 ± 9.8 135.8 ± 9.9 135.7 ± 9.9 53.75 ± 3.2 54.05 ± 4.5
omega 6:omega 3 0.053 ± 0.1 0.056 ± 0.1 0.056 ± 0.1 0.091 ± 0.2 0.096 ± 0.2
EPA 560.4 ± 0.2 570.2 ± 0.2 570.1 ± 0.1 203.8 ± 0.4 178.2 ± 0.6
DHA 174.2 ± 0.1 174.9 ± 0.1 175.1 ± 0 61.69 ± 0.1 85.05 ± 0.6
EPA:DHA 3.216 ± 2.6 3.261 ± 1.7 3.256 ± 11 3.303 ± 2.8 2.096 ± 1
EPA + DHA 734.6 ± 0.3 745.1 ± 0.3 745.2 ± 0.2 265.5 ± 0.5 263.3 ± 1.2
F G H I J
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Values are expressed as percent of total identified fatty acids ± standard deviation. Total SFA, total saturated fatty 
acids; Total Mono, total monounsaturated fatty acids; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. 
Table 3 expresses the total saturated fatty acids, total monounsaturated fatty acids, total 
omega-6 fatty acids, total omega-3 fatty acids, the omega-6 to omega-3 ratio, EPA content, DHA 
content, the ratio of EPA to DHA, along with the amount of EPA and DHA averaged across each 
pill.  EPA and DHA content range from 263 mg/g -894 mg/g EPA and DHA. 
DISCUSSION 
Much variance exists in composition and price of fish oil supplements. Results from these 
analyses should be useful for consumers regarding content and price per recommended serving 
of fish oil supplements. In reference to the analysis of these thirteen omega-3 supplements, the 
best value for the amount of EPA and DHA would be Kirkland Signature Natural Omega-3 Fish 
Oil at $0.03 per pill and $0.09 per day. This brand of fish oil supplement provides 900 mg EPA 
and DHA per day which exceeds the recommended dose of 250 mg per day, but provides an 
adequate dose in efforts to reduce triglycerides and provide beneficial effects.  
Sample K was an animal hospital fish oil supplement that was not in capsule form. The 
low EPA and DHA values may be due to a higher required dosage, or a difference in dosage 
mg/g methylated oil  K
Total SFA 42.25 ± 7.8 81.06 ± 12 103.1 ± 18
Total Mono 60.27 ± 17 63.49 ± 8.1 23.58 ± 6.8
omega 6 72.88 ± 27 5.695 ± 0.9 19.56 ± 6.2
omega 3 12.94 ± 3.8 56.16 ± 4.9 59.42 ± 20
omega 6:omega 3 5.631 ± 7 0.101 ± 0.2 0.329 ± 0.3
EPA 5.006 ± 0 179.8 ± 0.1 12.83 ± 0.3
DHA 5.2 ± 0 91.66 ± 0.1 326.9 ± 0.4
EPA:DHA 0.963 ± 0.6 1.961 ± 1.3 0.039 ± 0.6
EPA + DHA 10.21 ± 0 271.4 ± 0.2 339.7 ± 0.7
L M
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recommendations for animals, but no data was available for analysis. In future directions, this 
should be replaced with a brand for which data is available.  
Dosage must be taken into consideration when analyzing the total amount of EPA and 
DHA that would be consumed with supplementation of the various brands. For example, 
although sample B (Nature Made), C (Origin), I (Origin, Odorless), J (Kirkland Signature) and L 
(Nordic Naturals) have lower amounts of EPA and DHA, the dosage of the brands is 2-3 softgels 
per day. Whereas D (Vital Oils), E (Origin Triple Strength), F (Member’s Mark Triple Strength), 
G (Finest Natural) and H(Spring Valley) have dosages of 1 softgel daily. The more concentrated 
fish oil supplements with a dosage of one softgel daily were found to be slightly more expensive 
than the brands that require 2-3 softgels daily to achieve the recommended dosage. Thus, if a 
consumer is more concerned with the issue of the cost of a supplement, they would be best 
advised to choose a brand such as Kirkland Signature Natural Omega-3 Fish Oil which would 
cost them $0.09 per day to get 900 mg EPA and DHA. However, if a consumer is more 
concerned with not being able to remember to take a fish oil supplement three times per day, 
then they should choose a brand like Finest Natural that will cost them $0.20 per day, but they 
will only have to take one softgel per day to get the 900 mg EPA and DHA.  
Taking a fish oil supplement could enhance the health and quality of life for those 
suffering from diseases that may be prevented with adequate dietary intake of omega-3 fatty 
acids .   Our findings suggest that there are a few supplements that are more affordable than 
others.  Choosing an affordable supplement is possible but requires that consumers are aware of 
content of supplements as well as recommendations for health benefits. Fish oil supplementation 
has the potential to not only save lives, but also to save billions of dollars that are currently spent 
on preventable diseases.  
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LIMITATIONS AND FUTURE DIRECTIONS 
 Several issues to consider that may have influenced the results of my data were the 
storage of the pills, the amount of pills that were available for analysis, and the prices that were 
used for the cost analysis. Pills were kept at room temperature, but they were not all purchased at 
the same time, so ages of the supplements could have varied. Also, for certain brands, only one 
or two pills were available for analysis whereas other brands could each have samples taken 
from separate pills. In terms of pricing of the fish oil supplements, an average was taken of the 
varied prices for each brand, but this could vary by state, store, and sales and promotions. 
In further work on this project, a more broad selection of brands would be beneficial to 
analyze. A pricing of brands across different stores would further help consumers to not only 
find out which supplement fits their needs best, but also where they can purchase this supplement 
at the most affordable price. Different forms of fish oil supplement besides the capsule form 
would also be interesting to analyze for compositional consistency. Another topic of interest 
would be the consistency of composition in pills within the same bottle. This might be difficult 
to design in that being sure to get all of the oil out of the pill would present a challenge.  
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